Get the SPI Wire

SUMMIT THERAPEUTICS INC.

NASDAQ:SMMT
Annual Meeting

of Shareholders

MEETING DATE

11/04/2026
DEF 14A FILED
10/19/2026
PUBLISHED
10/19/2026 11:01 am
TIME TO PUBLISH
10/21/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:SMMT · CUSIP 86627T108 · CLASS common stock · CIK 0001599298

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

0
FOR
1
AGAINST
0
WITHHOLD
1
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
To approve an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of common stock by 1,000,000,000 (from 1,000,000,000 to 2,000,000,000).
other
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states additional common stock could dilute voting power and discourage a change in control.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

0102a94b615a7b02c3815234aeabb29785734557004b9a5c4bfb01853c81e3ae

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates